Funded Tech Companies
NRG Therapeutics
NRG Therapeutics, operating out of Stevenage Herts, received equity investments from Novartis Venture Fund, Dementia Discovery Fund and Brandon Capital Partners.
Company Overview
Company Name
NRG Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Stevenage Bioscience Catalyst Gunnels Wood Road
Stevenage Herts, SG1 2FX
UK
Stevenage Herts, SG1 2FX
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
NRG Therapeutics is passionate about bringing new medicines and hope to the growing number of people worldwide living with debilitating neurodegenerative disorders. A neuroscience-focussed drug discovery company building a pipeline of disease modifying drug candidates, NRG Therapeutics is focused on therapeutic approaches that will restore mitochondrial function and slow or halt the progression of neurodegenerative diseases such as Parkinson's and Amyotrophic Lateral Sclerosis, ALS (also known as motor neurone disease, MND).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/8/2025
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Miller
Chief Operating Officer
Grant Hawthorne
Co-Founder
Anthony Rutter
Company Investors
- Novartis Venture Fund
- Dementia Discovery Fund
- Brandon Capital Partners
- British Business Bank
- Omega Funds
- M Ventures
- Parkinson's Virtual Biotech
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs